litlas
Log inCreate account

Frederick W. Miller

Active 1960–2026

155
Papers
25,971
Citations
96
h-index
149
i10-index

Citations

Citations per year for Frederick W. Miller1965: 3 citations1966: 4 citations1967: 4 citations1968: 2 citations1969: 6 citations1970: 4 citations1973: 3 citations1974: 18 citations1975: 17 citations1976: 11 citations1977: 14 citations1978: 11 citations1979: 11 citations1980: 6 citations1981: 6 citations1982: 17 citations1983: 13 citations1984: 7 citations1985: 9 citations1986: 6 citations1987: 10 citations1988: 6 citations1989: 5 citations1990: 15 citations1991: 11 citations1992: 27 citations1993: 38 citations1994: 39 citations1995: 56 citations1996: 24 citations1997: 49 citations1998: 46 citations1999: 37 citations2000: 80 citations2001: 46 citations2002: 97 citations2003: 101 citations2004: 66 citations2005: 97 citations2006: 129 citations2007: 145 citations2008: 124 citations2009: 148 citations2010: 142 citations2011: 193 citations2012: 179 citations2013: 220 citations2014: 153 citations2015: 172 citations2016: 200 citations2017: 183 citations2018: 269 citations2019: 618 citations2020: 593 citations2021: 634 citations2022: 581 citations2023: 350 citations2024: 736 citations2025: 305 citations2026: 8 citations1971–1972: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,932 citing papers, 26.4% of this breakdownChina: 543 citing papers, 7.4% of this breakdownUnited Kingdom: 525 citing papers, 7.2% of this breakdownItaly: 361 citing papers, 4.9% of this breakdownGermany: 339 citing papers, 4.6% of this breakdownFrance: 326 citing papers, 4.5% of this breakdownJapan: 307 citing papers, 4.2% of this breakdownCanada: 276 citing papers, 3.8% of this breakdownSweden: 235 citing papers, 3.2% of this breakdownSpain: 230 citing papers, 3.1% of this breakdownNetherlands: 199 citing papers, 2.7% of this breakdownAustralia: 187 citing papers, 2.6% of this breakdown
0%26.4%Other 25.4%

Institutions

Fields

  • Medicine73.6%
  • Biochemistry, Genetics and Molecular Biology16.1%
  • Immunology and Microbiology5.3%
  • Environmental Science1.2%
  • Neuroscience0.8%
  • Agricultural and Biological Sciences0.5%
  • Other2.5%

Topics

  • Inflammatory Myopathies and Dermatomyositis11.9%
  • Systemic Sclerosis and Related Diseases3.3%
  • Parkinson's Disease and Spinal Disorders3.2%
  • Systemic Lupus Erythematosus Research2.6%
  • Eosinophilic Disorders and Syndromes2.3%
  • Rheumatoid Arthritis Research and Therapies2%
  • Other74.7%

Coauthors

All papers

Open in search
  1. The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention

    Authors: Frederick W. Miller - Current Opinion in Immunology 2022 cited by 473

  2. 2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups

    Authors: Ingrid E. Lundberg, Anna Tjärnlund, Matteo Bottai, Victoria P. Werth, Clarissa Pilkington, Marianne de Visser, Lars Alfredsson, Anthony A. Amato, Richard J. Barohn, Matthew H. Liang, Jasvinder A. Singh, Rohit Aggarwal, Snjólaug Arnardottir, Hector Chinoy, Robert G. Cooper, Katalin Dankó, Mazen M. Dimachkie, Brian M. Feldman, Ignacio García‐De La Torre, Patrick Gordon, Taichi Hayashi, James D. Katz, Hitoshi Kohsaka, Peter A. Lachenbruch, Bianca Lang, Yuhui Li, Chester V. Oddis, Marzena Olesińska, Ann M. Reed, Lidia Rutkowska‐Sak, Helga Sanner, Albert Selva-O’Callaghan, Yeong‐Wook Song, Jiří Vencovský, Steven R. Ytterberg, Frederick W. Miller, Lisa G. Rider - Annals of the Rheumatic Diseases 2017 cited by 1,525

  3. Idiopathic Inflammatory Myopathies

    Authors: Lisa G. Rider, Frederick W. Miller - Primer on the Rheumatic Diseases 2008 cited by 200

  4. Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: A randomized, placebo‐phase trial

    Authors: Chester V. Oddis, Ann M. Reed, Rohit Aggarwal, Lisa G. Rider, Dana P. Ascherman, Marc C. Levesque, Richard J. Barohn, Brian M. Feldman, Michael O. Harris‐Love, Diane Koontz, Noreen Fertig, Stephanie Kelley, Sherrie L. Pryber, Frederick W. Miller, Howard E. Rockette, and the RIM Study Group - Arthritis & Rheumatism 2012 cited by 691

  5. Identification of distinctive interferon gene signatures in different types of myositis

    Authors: Iago Pinal‐Fernandez, María Casal-Domínguez, Assia Derfoul, Katherine Pak, Paul H. Plötz, Frederick W. Miller, José C. Milisenda, Josep M. Grau‐Junyent, Albert Selva-O’Callaghan, Julie J. Paik, Jemima Albayda, Lisa Christopher‐Stine, Thomas E. Lloyd, Andrea M. Corse, Andrew L. Mammen - Neurology 2019 cited by 225

  6. Machine learning algorithms reveal unique gene expression profiles in muscle biopsies from patients with different types of myositis

    Authors: Iago Pinal‐Fernandez, María Casal-Domínguez, Assia Derfoul, Katherine Pak, Frederick W. Miller, José C. Milisenda, Josep M. Grau‐Junyent, Albert Selva-O’Callaghan, Carme Carrión, Julie J. Paik, Jemima Albayda, Lisa Christopher‐Stine, Thomas E. Lloyd, Andrea M. Corse, Andrew L. Mammen - Annals of the Rheumatic Diseases 2020 cited by 154

  7. International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative

    Authors: Alexander Oldroyd, Jeffrey P. Callen, Hector Chinoy, Leland W.K. Chung, David Fiorentino, Patrick Gordon, Pedro Machado, Neil McHugh, Albert Selva-O’Callaghan, Jens Schmidt, Sarah Tansley, Ruth Ann Vleugels, Victoria P. Werth, Anthony A. Amato, Helena Andersson, Lilia Andrade-Ortega, Dana P. Ascherman, Olivier Benvéniste, Lorenzo Cavagna, Christina Charles-Shoeman, Benjamin F. Chong, Lisa Christopher‐Stine, Jennie T. Clarke, Emma J. Crosbie, Philip Crosbie, Sonye K. Danoff, Maryam Dastmalchi, Marianne De Visser, Paul F. Dellaripa, Louise Pyndt Diederichsen, Mazen M. Dimachkie, Erik Ensrud, Floranne C. Ernste, D. Gareth Evans, Manabu Fujimoto, Ignacio García‐De La Torre, Abraham García-Kutzbach, Zoltán Griger, Latika Gupta, Marie Hudson, Florenzo Iannone, David Isenberg, Joseph L. Jorizzo, Helen Kurtz, Masataka Kuwana, Vidya Limaye, Ingrid E. Lundberg, Andrew L. Mammen, H. Mann, Frank Mastaglia, Lorna McWilliams, Christopher A. Mecoli, Federica Meloni, Frederick W. Miller, Siamak Moghadam‐Kia, Sergey Moiseev, Yoshinao Muro, Melinda Nagy‐Vincze, Clive Nayler, Merrilee Needham, Ichizo Nishino, Chester V. Oddis, Julie J. Paik, Joost Raaphorst, Lisa G. Rider, Jorge Rojas‐Serrano, Lesley Ann Saketkoo, Adam Schiffenbauer, Samuel Katsuyuki Shinjo, Vineeta Shobha, Yeong‐Wook Song, Tania Tillett, Yves Troyanov, Anneke J. van der Kooi, Mónica Vázquez-Del Mercado, Jiří Vencovský, Qian Wang, Steven R. Ytterberg, Rohit Aggarwal - Nature Reviews Rheumatology 2023 cited by 139

  8. Increasing Prevalence of Antinuclear Antibodies in the United States

    Authors: Gregg E. Dinse, Christine G. Parks, Clarice R. Weinberg, Caroll A. Co, Jesse Wilkerson, Darryl C. Zeldin, Edward K. L. Chan, Frederick W. Miller - Arthritis & Rheumatology 2022 cited by 102

  9. Neutrophil dysregulation is pathogenic in idiopathic inflammatory myopathies

    Authors: Nickie Seto, Jose Jiram Torres-Ruiz, Carmelo Carmona‐Rivera, Iago Pinal‐Fernandez, Katherine Pak, Monica Purmalek, Yuji Hosono, Cátia Fernandes‐Cerqueira, P. Gowda, Nathan Arnett, Alexander M. Gorbach, Olivier Benvéniste, Diana Gómez‐Martín, Albert Selva-O’Callaghan, José C. Milisenda, Josep M. Grau‐Junyent, Lisa Christopher‐Stine, Frederick W. Miller, Ingrid E. Lundberg, J. Michelle Kahlenberg, Adam Schiffenbauer, Andrew L. Mammen, Lisa G. Rider, Mariana J. Kaplan - JCI Insight 2020 cited by 133

  10. Measuring Therapeutic Response in Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group Report

    Authors: Steven Z. Pavletic, Paul J. Martin, Stephanie J. Lee, Sandra A. Mitchell, David A. Jacobsohn, Edward W. Cowen, Maria L. Turner, Görgün Akpek, Andrew L. Gilman, George B. McDonald, Mark Schubert, Ann Berger, Peter Bross, Jason W. Chien, Daniel R. Couriel, James P. Dunn, Jane M. Fall‐Dickson, Ann T. Farrell, Mary E.D. Flowers, Hildegard Greinix, Steven Hirschfeld, Lynn H. Gerber, Stella Kim, Robert Knobler, Peter A. Lachenbruch, Frederick W. Miller, Barbara B. Mittleman, Esperanza B. Papadopoulos, Susan K. Parsons, Donna Przepiorka, M. Robinson, Michael E. Ward, Bryce B. Reeve, Lisa G. Rider, Howard M. Shulman, Kirk R. Schultz, Daniel Weisdorf, Georgia B. Vogelsang - Biology of Blood and Marrow Transplantation 2006 cited by 565

  11. Prevalence and sociodemographic correlates of antinuclear antibodies in the United States

    Authors: Minoru Satoh, Edward K. L. Chan, Lindsey A. Ho, Kathryn M. Rose, Christine G. Parks, Richard D. Cohn, Todd A. Jusko, Nigel J. Walker, Dori R. Germolec, Irene Whitt, Patrick W. Crockett, Brad A. Pauley, Jason Chan, Steven J. Ross, Linda S. Birnbaum, Darryl C. Zeldin, Frederick W. Miller - Arthritis & Rheumatism 2012 cited by 450

  12. Retracted: Increasing Prevalence of Antinuclear Antibodies in the United States

    Authors: Gregg E. Dinse, Christine G. Parks, Clarice R. Weinberg, Caroll A. Co, Jesse Wilkerson, Darryl C. Zeldin, Edward K. L. Chan, Frederick W. Miller - Arthritis & Rheumatology 2020 cited by 192

  13. Risk factors and disease mechanisms in myositis

    Authors: Frederick W. Miller, Janine A. Lamb, Jens Schmidt, Kanneboyina Nagaraju - Nature Reviews Rheumatology 2018 cited by 197

  14. Expression of interferon-regulated genes in juvenile dermatomyositis versus Mendelian autoinflammatory interferonopathies

    Authors: Hanna Kim, Fatima Gunter‐Rahman, John A. McGrath, Esther Lee, Adriana A. de Jesus, Ira N. Targoff, Yan Huang, Terrance P. OʼHanlon, Wanxia Li Tsai, Massimo Gadina, Frederick W. Miller, Raphaela Goldbach‐Mansky, Lisa G. Rider - Arthritis Research & Therapy 2020 cited by 66

  15. Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C‐HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF‐36), Child Health Questionnaire (CHQ), Physician Global Damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index‐2 (FI‐2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI)

    Authors: Lisa G. Rider, Victoria P. Werth, Adam M. Huber, Helene Alexanderson, Anand Rao, Nicolino Ruperto, Laura Herbelin, Richard J. Barohn, David Isenberg, Frederick W. Miller - Arthritis Care & Research 2011 cited by 440

  16. Predictors of Clinical Improvement in Rituximab‐Treated Refractory Adult and Juvenile Dermatomyositis and Adult Polymyositis

    Authors: Rohit Aggarwal, Andriy I. Bandos, Ann M. Reed, Dana P. Ascherman, Richard J. Barohn, Brian M. Feldman, Frederick W. Miller, Lisa G. Rider, Michael O. Harris‐Love, Marc C. Levesque, the RIM Study Group, Chester V. Oddis - Arthritis & Rheumatology 2013 cited by 282

  17. 2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis

    Authors: Rohit Aggarwal, Lisa G. Rider, Nicolino Ruperto, Nastaran Bayat, Brian Erman, Brian M. Feldman, Chester V. Oddis, Anthony A. Amato, Hector Chinoy, Robert G. Cooper, Maryam Dastmalchi, David Fiorentino, David Isenberg, James D. Katz, Andrew L. Mammen, Marianne de Visser, Steven R. Ytterberg, Ingrid E. Lundberg, Lorinda Chung, Katalin Dankó, Ignacio García‐De La Torre, Yeong Wook Song, Luca Villa, Mariangela Rinaldi, Howard E. Rockette, Peter A. Lachenbruch, Frederick W. Miller, Jiří Vencovský - Annals of the Rheumatic Diseases 2017 cited by 169

  18. Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroups

    Authors: Simon Rothwell, Hector Chinoy, Janine A. Lamb, Frederick W. Miller, Lisa G. Rider, Lucy R. Wedderburn, Neil McHugh, Andrew L. Mammen, Zoë Betteridge, Sarah Tansley, John Bowes, Jiří Vencovský, Claire T. Deakin, Katalin Dankó, Limaye Vidya, Albert Selva-O’Callaghan, Lauren M. Pachman, Ann M. Reed, Øyvind Molberg, Olivier Benvéniste, Pernille Mathiesen, Timothy R. D. J. Radstake, Andrea Doria, Jan De Bleecker, Annette T. Lee, Michael G. Hanna, Pedro Machado, William Ollier, Peter K. Gregersen, Leonid Padyukov, Terrance P. OʼHanlon, Robert G. Cooper, Ingrid E. Lundberg - Annals of the Rheumatic Diseases 2019 cited by 121

  19. Inflammatory Bowel Disease Prevalence: Surveillance data from the U.S. National Health and Nutrition Examination Survey

    Authors: Michael H. Weisman, Oleg Stens, Hyun‐Seok Kim, Jason K. Hou, Frederick W. Miller, Charles Dillon - Preventive Medicine Reports 2023 cited by 48

  20. Aristolochic acid and the etiology of endemic (Balkan) nephropathy

    Authors: Arthur P. Grollman, Shinya Shibutani, Masaaki Moriya, Frederick W. Miller, Lin Wu, Ute M. Moll, Naomi Suzuki, Andrea Fernandes, Thomas A. Rosenquist, Zvonimir Medverec, Krunoslav Jakovina, Branko Brdar, Neda Slade, Robert J. Turesky, Angela K. Goodenough, Robert Rieger, Mato Vukelić, Bojan Jelaković - National Academy of Sciences, Proceedings of the National Academy of Sciences 2007 cited by 599

  21. Diagnosis and classification of idiopathic inflammatory myopathies

    Authors: Ingrid E. Lundberg, Frederick W. Miller, Anna Tjärnlund, Matteo Bottai - Journal of Internal Medicine 2016 cited by 214

  22. Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups

    Authors: Simon Rothwell, Robert G. Cooper, Ingrid E. Lundberg, Frederick W. Miller, Peter K. Gregersen, John Bowes, Jiří Vencovský, Katalin Dankó, Vidya Limaye, Albert Selva-O’Callaghan, Michael G. Hanna, Pedro Machado, Lauren M. Pachman, Ann M. Reed, Lisa G. Rider, Joanna Cobb, Hazel Platt, Øyvind Molberg, Olivier Benvéniste, Pernille Mathiesen, Timothy Radstake, Andrea Doria, Jan De Bleecker, Boél De Paepe, Britta Maurer, William Ollier, Leonid Padyukov, Terrance P. OʼHanlon, Annette Lee, Christopher I. Amos, Christian Gieger, Thomas Meitinger, Juliane Winkelmann, Lucy R. Wedderburn, Hector Chinoy, Janine A. Lamb - Annals of the Rheumatic Diseases 2016 cited by 164

  23. Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis

    Authors: Sara Sabbagh, Iago Pinal‐Fernandez, Takayuki Kishi, Ira N. Targoff, Frederick W. Miller, Lisa G. Rider, Andrew L. Mammen - Annals of the Rheumatic Diseases 2019 cited by 151

  24. Defining anti-synthetase syndrome: a systematic literature review

    Authors: Giovanni Zanframundo, Sara Faghihi-Kashani, Carlo Alberto Scirè, Francesco Bonella, Tamera J. Corte, Tracy J. Doyle, David Fiorentino, Miguel Á. González‐Gay, Marie Hudson, Masataka Kuwana, Ingrid E. Lundberg, Andrew L. Mammen, Neil McHugh, Frederick W. Miller, Carlomaurizio Monteccucco, Chester V. Oddis, Jorge Rojas‐Serrano, Jens Schmidt, Albert Selva-O’Callaghan, Victoria P. Werth, Garifallia Sakellariou, Rohit Aggarwal, Lorenzo Cavagna - Clinical and Experimental Rheumatology 2022 cited by 81